TScan Therapeutics TCRX Q1 2026 Miss What Went Wrong Aeluma Reports Higher Revenue but Wider Loss Bolsters Cash Position Global MA Deal Volumes A FourDecade Trajectory Through 2025 Psyence PBM Declines 1518 Amid Market Weakness 20260520 AI Money Is Pushing San Francisco Housing Prices Way Up Even Before the OpenAI and Anthropic IPOs